Bachem and Dottikon ES will jointly develop, manufacture and distribute innovative, enantiomerically pure amino acids. These can be used, for example, for peptide synthesis, explains the Bachem Group, which is headquartered in Bubendorf in the canton of Basel-Landschaft.
Bachem describes itself as the global leader in “exclusive custom synthesis of peptides for preclinical and clinical pharmaceutical research”. Dottikon ES manufactures high-quality, intermediates and exclusive active pharmaceutical ingredients for the chemical and pharmaceutical industry.
“We are pleased to collaborate with Dottikon ES to bring innovative, new amino acid derivatives for peptide synthesis to our worldwide customer base. Due to the special chemical skills of Dottikon ES, special, enantiomerically pure amino acid derivatives of high quality can be manufactured very efficiently,” said José de Chastonay, Chief Marketing Officer of Bachem Holding AG.
